Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1

Journal of the National Cancer Institute

Volumn 96, Issue 11, 2004, Pages 862-872

  Spänkuch, Birgit ^a   Matthess, Yves ^a   Knecht, Rainald ^a   Zimmer, Brigitte ^a   Kaufmann, Manfred ^a   Strebhardt, Klaus ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AURINTRICARBOXYLIC ACID; MESSENGER RNA; NUCLEASE; PLASMID DNA; POLO LIKE KINASE 1; PROTEIN KINASE; RNA; UNCLASSIFIED DRUG; ACTIN; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; DNA; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; SMALL NUCLEAR RNA; U6 SMALL NUCLEAR RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GENE DELIVERY SYSTEM; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; STATISTICAL ANALYSIS; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASM; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; XENOGRAFT;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL CYCLE PROTEINS; DNA, NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICE; MICE, NUDE; NEOPLASMS; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; RNA, SMALL NUCLEAR; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 2942544699     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh146     Document Type: Article

References (33)

1. Hannon GJ. RNA interference. Nature 2002;418:244-51.
2. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002;3:737-47.
3. Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002;20: 446-8.
4. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
5. Hannon GJ, Chubb A, Maroney PA, Hannon G, Altman S, Nilsen TW. Multiple cis-acting elements are required for RNA polymerase III transcription of the gene encoding H1 RNA, the RNA component of human RNase P. J Biol Chem 1991;266:22796-9.
6. Lobo SM, Ifill S, Hernandez N. cis-acting elements required for RNA polymerase II and III transcription in the human U2 and U6 snRNA promoters. Nucleic Acids Res 1990;18:2891-9.
7. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-5.
8. Chong SS, Hu P, Hernandez N. Reconstitution of transcription from the human U6 small nuclear RNA promoter with eight recombinant polypeptides and a partially purified RNA polymerase III complex. J Biol Chem 2001;276:20727-34.
9. Paul CP, Good PD, Winer I, Engelke DR. Effective expression of small interfering RNA in human cells. Nat Biotechnol 2002;20:505-8.
10. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci U S A 2002;99:5515-20.
11. Yu YT, Maroney PA, Darzynkiwicz E, Nilsen TW. U6 snRNA function in nuclear pre-mRNA splicing: a phosphorothioate interference analysis of the U6 phosphate backbone. RNA 1995;1:46-54.
12. Spankuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst 2002;94:1863-77.
13. Glover DM, Hagan IM, Tavares AA. Polo-like kinases: a team that plays throughout mitosis. Genes Dev 1998;12:3777-87.
14. Strebhardt K. PLK (polo-like kinase). In: Creighton TE, editor. Encyclopedia of molecular medicine. New York (NY): Wiley and Sons; 2001. p. 2530-2532.
15. Brummelkamp T, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002;2:243.
16. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
17. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002;418:38-9.
18. Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002;20:1006-10.
19. Schleef M, Schmidt T. Animal-free production of ccc-supercoiled plasmids for research and clinical applications. J Gene Med 2004;6 Suppl 1:S45-53.
20. Kauselmann G, Weiler M, Wulff P, Jessberger S, Konietzko U, Scafidi J, et al. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)-and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J 1999;18:5528-39.
21. Yuan J, Horlin A, Hock B, Stutte HJ, Rubsamen-Waigmann H, Strebhardt K. Polo-like kinase, a novel marker for cellular proliferation. Am J Pathol 1997;150:1165-72.
22. Blumenthal T, Landers TA. The inhibition of nucleic acid-binding proteins by aurintricarboxylic acid. Biochem Biophys Res Commun 1973;55: 680-8.
23. Spankuch-Schmitt B, Wolf G, Solbach C, Loibl S, Knecht R, Stegmuller M, et al. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells. Oncogene 2002; 21:3162-71.
24. Lee KS, Yuan YL, Kuriyama R, Erikson RL. Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol Cell Biol 1995;15:7143-51.
25. Hallick RB, Chelm BK, Gray PW, Orozco EM Jr. Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation. Nucleic Acids Res 1977;4:3055-64.
26. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9:347-51.
27. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003;21:639-44.
28. Vorburger SA, Hunt KK. Adenoviral gene therapy. Oncologist 2002;7:46-59.
29. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, et al. Murine leukemia induced by retroviral gene marking. Science 2002;296: 497.
30. Marshall E. Clinical research. Gene therapy a suspect in leukemia-like disease. Science 2002;298:34-5.
31. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science 2003;299:320.
32. Glasspool-Malone J, Steenland PR, McDonald RJ, Sanchez RA, Watts TL, Zabner J, et al. DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor. J Gene Med 2002;4: 323-32.
33. Alwayn IP, Appel JZ, Goepfert C, Buhler L, Cooper DK, Robson SC. Inhibition of platelet aggregation in baboons: therapeutic implications for xenotransplantation. Xenotransplantation 2000;7:247-57.